[Skip to Content]
[Skip to Content Landing]
December 1985

News and Notes

Arch Dermatol. 1985;121(12):1496. doi:10.1001/archderm.1985.01660120022011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


FOR CLASS 1 POTENCY1 DIPROLENE® brand of betamethasone dipropionate Ointment, USP, 0.05%— IN ACTIBASE (potency expressed as betamethasone) For Dermatologic Use Only — Not for Ophthalmic Use Summary of Prescribing Information: INDICATIONS AND USAGE DIPROLENE Ointment is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. CONTRAINDICATIONS DIPROLENE Ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. PRECAUTIONS General Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. Conditions which augment systemic absorption include the application of the more potent corticosteroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. See DOSAGE AND ADMINISTRATION section.) Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area should be evaluated periodically for evidence of

First Page Preview View Large
First page PDF preview
First page PDF preview